| ■ 英語タイトル：Global Degenerative Disc Disease Treatment Market Size study & Forecast, by Type (Conventional Drugs, Novel Therapies) by End-user (Hospitals, Clinics, Others) and Regional Analysis, 2022-2029
|
 | ■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23MR065
■ 発行日：2023年2月27日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
|
■ 販売価格オプション
（消費税別）
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
| ★グローバルリサーチ資料[変性椎間板疾患治療のグローバル市場（2022年-2029年）：従来型医薬品、新規療法]についてメールでお問い合わせはこちら
|
*** レポート概要（サマリー）***Bizwit Research社の市場調査レポートは、2021年に260.5億ドルであった世界の変性椎間板疾患治療市場規模が、2022年から2029年の間に7.4%成長すると推測しています。本書では、変性椎間板疾患治療の世界市場を広く調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別（従来型医薬品、新規療法）分析、エンドユーザー別（病院、診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他）分析、競争状況、調査プロセスなどについて以下の構成でまとめています。なお、参入企業情報として、B. Braun Melsungen AG、Pfizer Inc.、Novartis AG、Eli Lilly and Company、DiscGenics, Inc.、Spine BioPharma、FibroGenesis、Ferring B.V.、Globus Medical、Paradigm Spine LLCなどが含まれています。・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の変性椎間板疾患治療市場規模：種類別
- 従来型医薬品の市場規模
- 新規療法の市場規模
・世界の変性椎間板疾患治療市場規模：エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- その他エンドユーザーにおける市場規模
・世界の変性椎間板疾患治療市場規模：地域別
- 北米の変性椎間板疾患治療市場規模
- ヨーロッパの変性椎間板疾患治療市場規模
- アジア太平洋の変性椎間板疾患治療市場規模
- 中南米の変性椎間板疾患治療市場規模
- その他地域の変性椎間板疾患治療市場規模
・競争状況
・調査プロセス |
Global Degenerative Disc Disease Treatment Market is valued at approximately USD 26.05 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Degenerative disc disease (DDD) is a medical condition that results in the degeneration of one or more discs between the vertebrae of the spinal column. In that condition, the injured spinal disc leads patients to have chronic low back discomfort and potentially causes long-term impairment. the treatment involves muscle relaxers, pain relief medications, steroids, and Non-steroidal Anti-inflammatory Drugs (NSAIDs). The growing availability of both non-surgical and spinal fusion process, rising clinical approvals, and increasing healthcare expenditure are some chief factors that are surging the market demand in the global market.
The rising prevalence of chronic lower back pain is bolstering the need for degenerative disc disease therapy among the population, especially among senior people. For instance, the International Association for the Study of Pain published statistics from 2021 that predicted the point prevalence of low back pain (LBP) to be around 7.5% of the world’s population. Similarly, a 2021 article from the National Centers for Biotechnology Information (NCBI) reported that the prevalence of disc degeneration was 12.4% in the population between the ages of 18 and 29 and soared to 98.2% in those between the ages of 60 and 69. Therefore, these aforementioned factors are stipulating the market growth across the globe. Moreover, the rising launch of innovative and technologically advanced products, as well as the growing R&D investments are presenting various lucrative opportunities over the forecasting years. However, limited availability of effective drugs and novel therapies for the treatment of this condition and presence of alternative therapies are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Degenerative Disc Disease Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing adoption of drugs and treatments among the patient population, along with the rising prevalence of the condition, Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the surging demand for the drugs for various treatment, escalating target population, as well as increasing diagnosis of the condition in the market space.
Major market players included in this report are:
B. Braun Melsungen AG
Pfizer Inc.
Novartis AG
Eli Lilly and Company
DiscGenics, Inc.
Spine BioPharma
FibroGenesis
Ferring B.V.
Globus Medical
Paradigm Spine LLC
Recent Developments in the Market:
In March 2022, Pfizer Inc. announced the acquisition of Arena- a clinical-stage company developing innovative potential therapies to cure immuno-inflammatory diseases. The primary objective of this initiative is the strengthening of the product portfolio.
In December 2021, Teva Pharmaceutical Industries Ltd. declared the introduction of Ibuprofen 800 mg tablets, the generic version of Duexis, indicated for pain management in the U.S., which aims to boost the company’s product portfolio.
Global Degenerative Disc Disease Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Conventional Drugs
Novel Therapies
By End-user:
Hospitals
Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Degenerative Disc Disease Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Degenerative Disc Disease Treatment Market, by Type, 2019-2029 (USD Billion)
1.2.3. Degenerative Disc Disease Treatment Market, by End-user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Degenerative Disc Disease Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Degenerative Disc Disease Treatment Market Dynamics
3.1. Degenerative Disc Disease Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of chronic lower back pain and degenerative disc disease
3.1.1.2. Growing availability of both non-surgical and spinal fusion process
3.1.2. Market Challenges
3.1.2.1. Limited availability of effective drugs and novel therapies for the treatment of this condition
3.1.2.2. Presence of alternative therapies
3.1.3. Market Opportunities
3.1.3.1. Rising launch of innovative and technologically advanced products
3.1.3.2. Growing R&D investments
Chapter 4. Global Degenerative Disc Disease Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Degenerative Disc Disease Treatment Market, by Type
6.1. Market Snapshot
6.2. Global Degenerative Disc Disease Treatment Market by Type, Performance – Potential Analysis
6.3. Global Degenerative Disc Disease Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Degenerative Disc Disease Treatment Market, Sub Segment Analysis
6.4.1. Conventional Drugs
6.4.2. Novel Therapies
Chapter 7. Global Degenerative Disc Disease Treatment Market, by End-user
7.1. Market Snapshot
7.2. Global Degenerative Disc Disease Treatment Market by End-user, Performance – Potential Analysis
7.3. Global Degenerative Disc Disease Treatment Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
7.4. Degenerative Disc Disease Treatment Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others
Chapter 8. Global Degenerative Disc Disease Treatment Market, Regional Analysis
8.1. Degenerative Disc Disease Treatment Market, Regional Market Snapshot
8.2. North America Degenerative Disc Disease Treatment Market
8.2.1. U.S. Degenerative Disc Disease Treatment Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. End-user breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Degenerative Disc Disease Treatment Market
8.3. Europe Degenerative Disc Disease Treatment Market Snapshot
8.3.1. U.K. Degenerative Disc Disease Treatment Market
8.3.2. Germany Degenerative Disc Disease Treatment Market
8.3.3. France Degenerative Disc Disease Treatment Market
8.3.4. Spain Degenerative Disc Disease Treatment Market
8.3.5. Italy Degenerative Disc Disease Treatment Market
8.3.6. Rest of Europe Degenerative Disc Disease Treatment Market
8.4. Asia-Pacific Degenerative Disc Disease Treatment Market Snapshot
8.4.1. China Degenerative Disc Disease Treatment Market
8.4.2. India Degenerative Disc Disease Treatment Market
8.4.3. Japan Degenerative Disc Disease Treatment Market
8.4.4. Australia Degenerative Disc Disease Treatment Market
8.4.5. South Korea Degenerative Disc Disease Treatment Market
8.4.6. Rest of Asia Pacific Degenerative Disc Disease Treatment Market
8.5. Latin America Degenerative Disc Disease Treatment Market Snapshot
8.5.1. Brazil Degenerative Disc Disease Treatment Market
8.5.2. Mexico Degenerative Disc Disease Treatment Market
8.5.3. Rest of Latin America Degenerative Disc Disease Treatment Market
8.6. Rest of The World Degenerative Disc Disease Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. B. Braun Melsungen AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Pfizer Inc.
9.2.3. Novartis AG
9.2.4. Eli Lilly and Company
9.2.5. DiscGenics, Inc.
9.2.6. Spine BioPharma
9.2.7. FibroGenesis
9.2.8. Ferring B.V.
9.2.9. Globus Medical
9.2.10. Paradigm Spine LLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
*** 免責事項 ***https://www.globalresearch.co.jp/disclaimer/
